ATP citrate lyase is an essential player of the metabolic rewiring induced by PTEN loss during T-ALL development.
G. Andrieu, G. Hypolite, E. Balducci, C. Costa, E. Verhoeyen, I. Nemazanyy, G. Panasyuk, K. Wellen, E. Macintyre, V. Asnafi, M. Tesio
This study identifies ATP citrate lyase (ACLY) as a critical metabolic driver in PTEN-deficient T-ALL, showing its essential role in disease progression and therapeutic targeting potential.
bioRxiv · Mar 27, 2023Cancer Biology